(Press-News.org) Scientists at the University of East Anglia, University of Barcelona, University Pompeu Fabra and several other European institutions have found a way to separate the medical benefits of cannabis from some of its unwanted side effects.
The research comes from the team that had previously discovered how the main psychoactive ingredient in cannabis, known as tetrahydrocannabinol or THC, reduces tumour growth in cancer patients.
Their latest findings, publishing on July 9th in the Open Access journal PLOS Biology, reveal how some detrimental cognitive effects of THC are triggered by a pathway which is separate from some of its other effects.
That pathway involves both a cannabinoid receptor and a serotonin receptor. When it is blocked, THC can still exert several beneficial effects - including pain relief - while avoiding impairment of memory.
The research was carried out in mice, but it is hoped that the breakthrough will pave the way for safe cannabis-based therapies that do not cause alterations in mood, perception or memory.
Dr Peter McCormick, from University of East Anglia's school of Pharmacy, said: "THC, the major active component of marijuana, has broad medical use - including for pain relief, nausea and anxiety. Our previous research has also found that it could reduce tumour size in cancer patients. However it is also known to induce numerous undesirable side effects such as memory impairment, anxiety, and dependence. There has been a great deal of medical interest in understanding the molecular mechanisms at work in THC, so that the beneficial effects can be harnessed without the side-effects. THC acts through a family of cell receptors called cannabinoid receptors. Our previous research revealed which of these receptors are responsible for the anti-tumour effects of THC. This new research demonstrates how some of the drug's beneficial effects can be separated from some its unwanted side effects."
The research team carried out behavioural studies in mice and investigated how pathways in their brains operate under THC. They found that the absence of a particular serotonin receptor known as 5HT2AR reduced some of the detrimental cognitive effects of THC - such as amnesia. However, the treatment to reduce 5HT2AR did not change the beneficial effect of THC on pain relief.
"This research is important because it identifies a way to reduce some of what, in medical treatment, are usually thought of as THC's unwanted side effects, while maintaining several important benefits including pain reduction", said Dr McCormick.
However, he warned that patients should not be tempted to self-medicate, "patients should not use cannabis to self-medicate, but I hope that our research will lead to a safe synthetic equivalent being available in the future."
INFORMATION:
Please mention PLOS Biology as the source for this article and include the links below in your coverage to take readers to the online, open access articles.
All works published in PLOS Biology are open access, which means that everything is immediately and freely available. Use this URL in your coverage to provide readers access to the paper upon publication:
http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002194
Contact:
Lisa Horton
tel: +44 (0)1603 592764
email: l.horton@uea.ac.uk
Citation: Viñals X, Moreno E, Lanfumey L, Cordomí A, Pastor A, de La Torre R, et al. (2015) Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS Biol 13(7): e1002194. doi:10.1371/journal.pbio.1002194
Funding: This study was supported by grants from the Spanish 'Ministerio de Ciencia e Innovación'
(SAF2011-29864) to RM, (SAF2010-18472) to PJM and (SAF2011-23813) to EC. 'Ministerio de Economía y Competitividad' (SAF2014-59648-P) to RM. The Spanish 'Instituto de Salud Carlos III' (P1070709 and PI14/00210) to PR and (RD06/001/001) to RM, the Catalan government (SGR2009-
00131) to RM. PJM was supported by a Ramon y Cajal Fellow and internal funds from UEA, and PJM and LP participate in the European COST Action CM 1207 (GLISTEN). FEDER funds partial support is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Many animals actively touch objects in their environment and respond to them by appropriate movement sequences. Jan Ache and Volker Dürr from Bielefeld University in Germany present a model in PLOS Computational Biology that captures key properties of a wide variety of descending neurons that are part of an "active touch system".
Goal-directed actions require neurons that descend from the brain to lower parts of the nervous system, for example: to distribute sensory information to local modules of movement control. Stick insects actively explore the near-range environment ...
In a genome-sequencing study of pancreatic cancers and blood in 101 patients, Johns Hopkins Kimmel Cancer Center scientists say they found at least one-third of the patients' tumors have genetic mutations that may someday help guide precision therapy of their disease. Results of blood tests to detect DNA shed from tumors, they say, also predicted cancer recurrence more than half a year earlier than standard imaging methods.
"Pancreatic cancer has one of the highest death rates among cancer types. Many people think there are no treatment options, but our study shows that ...
Washington, DC--People who have diabetes and experience high rates of complications are more likely to develop dementia as they age than people who have fewer diabetic complications, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
An individual develops diabetes when the pancreas doesn't produce enough of the hormone insulin or the body can't use insulin properly to process sugar. When blood sugar levels remain high due to uncontrolled diabetes, serious complications can develop, including blindness, kidney ...
Washington, DC--Men who have ejaculatory disorders and low testosterone levels did not experience improved sexual function after undergoing testosterone replacement therapy, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Estimates indicate between 10 percent and 18 percent of men have problems with inability to ejaculate, decreased volume of ejaculation, decreased force of ejaculation and delayed time to ejaculation. This is a separate neurobiological problem from erectile dysfunction, and there is no FDA-approved ...
PITTSBURGH, July 9, 2015 - Starting anti-HIV treatment within two weeks of the diagnosis of tuberculosis, or TB, improved survival among patients with both infections who had very low immune-cell counts, according to an analysis by researchers at the University of Pittsburgh Graduate School of Health. Those with strong immune systems, however, might benefit from waiting until after the end of the six-month TB treatment before initiating anti-HIV therapy, they found.
In a study published in the current issue of Annals of Internal Medicine, the team recommended updating ...
In Borneo, some insectivorous bats have developed a rather intriguing relationship with carnivorous pitcher plants. The plants offer the bats a relatively cool place to roost, free of parasites and competition from other bats. In return, the bats keep the plants well fertilized with their droppings. Now, researchers reporting in the Cell Press journal Current Biology on July 9 show that the plants rely on special structures to reflect the bats' ultrasonic calls back to them. That adaptation of the plants makes it easier for bats to find their plant partners in the cluttered ...
A new technique that uses light to activate chemotherapy drugs in specific cells shows promise as a way to improve the effectiveness of cancer therapies while preventing severe side effects, according to a study published July 9 in Cell. The so-called photopharmacology approach could be used to treat a broad range of tumors with unprecedented precision simply by making existing cancer drugs sensitive to light--an approach that requires less time and effort compared with traditional drug discovery programs.
"We hope that our compounds will one day be used in medicine to ...
CAMBRIDGE, MA -- The "friendly" bacteria inside our digestive systems are being given an upgrade, which may one day allow them to be programmed to detect and ultimately treat diseases such as colon cancer and immune disorders.
In a paper published today in the journal Cell Systems, researchers at MIT unveil a series of sensors, memory switches, and circuits that can be encoded in the common human gut bacterium Bacteroides thetaiotaomicron.
These basic computing elements will allow the bacteria to sense, memorize, and respond to signals in the gut, with future applications ...
While human activities have caused extinctions across the globe, your favourite beach or diving site may actually be home to as many, or more, species then it was a few decades ago.
That's the conclusion of a synthesis of 50 years of marine biodiversity data conducted by University of British Columbia (UBC) researchers.
But there is a catch. Like other studies of its kind, the synthesis relies on species population time series from sites that haven't been subject to intense human development.
"Much as you'd expect, our study shows human impacts like pollution and ...
A study to examine recessively inherited genome-wide DNA sequences has for the first time discovered a potential link with Britain's biggest killer - Coronary Artery Disease (CAD).
The research led by a team from the University of Leicester was the first time that recessively inherited DNA sequences in the whole genome called Runs of homozygosity (ROHs) were examined for a connection to the disease.
The study appears in the American Journal of Human Genetics.
CAD is a terminal clinical manifestation of cardiovascular disease and is the leading cause of death worldwide ...
